ArticleHemaSphere2025
Uncovering regulatory B-cell features associated with regulatory T-cell expansion and global T-cell exhaustion in Waldenström macroglobulinemia
Quentin Lemasson, Maxime Tabaud, Ophélie Téteau, Bastien Carle, Mina Chabaud, Jean Feuillard, Nathalie Faumont, Christelle Vincent-Fabert
Abstract read
In one paragraphArticle in HemaSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Quentin LemassonUMR CNRS7276, Inserm1262 University of Limoges: Contrôle de la Réponse Immune B et des Lymphoproliférations, Team 1, 2MB2C: Molecular Mechanisms of B Cell Cancerogenesis Limoges France.
Maxime TabaudUMR CNRS7276, Inserm1262 University of Limoges: Contrôle de la Réponse Immune B et des Lymphoproliférations, Team 1, 2MB2C: Molecular Mechanisms of B Cell Cancerogenesis Limoges France.
Ophélie TéteauUMR CNRS7276, Inserm1262 University of Limoges: Contrôle de la Réponse Immune B et des Lymphoproliférations, Team 1, 2MB2C: Molecular Mechanisms of B Cell Cancerogenesis Limoges France.
Bastien CarleUMR CNRS7276, Inserm1262 University of Limoges: Contrôle de la Réponse Immune B et des Lymphoproliférations, Team 1, 2MB2C: Molecular Mechanisms of B Cell Cancerogenesis Limoges France.
Mina ChabaudUMR CNRS7276, Inserm1262 University of Limoges: Contrôle de la Réponse Immune B et des Lymphoproliférations, Team 1, 2MB2C: Molecular Mechanisms of B Cell Cancerogenesis Limoges France.
Jean FeuillardUMR CNRS7276, Inserm1262 University of Limoges: Contrôle de la Réponse Immune B et des Lymphoproliférations, Team 1, 2MB2C: Molecular Mechanisms of B Cell Cancerogenesis Limoges France.
Nathalie FaumontUMR CNRS7276, Inserm1262 University of Limoges: Contrôle de la Réponse Immune B et des Lymphoproliférations, Team 1, 2MB2C: Molecular Mechanisms of B Cell Cancerogenesis Limoges France.
Christelle Vincent-FabertUMR CNRS7276, Inserm1262 University of Limoges: Contrôle de la Réponse Immune B et des Lymphoproliférations, Team 1, 2MB2C: Molecular Mechanisms of B Cell Cancerogenesis Limoges France.ORCID https://orcid.org/0000-0002-5799-980X Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Waldenström's macroglobulinemia (WM) is a rare, indolent lymphoproliferative disorder, genetically characterized by the presence of the
Identifiers
PMID41180901
PMCPMC12573103
What Socratic holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390